WEST PHARMACEUTICAL SERVICES, INC. Foreign Currency Transaction Gain (Loss), before Tax
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Foreign Currency Transaction Gain (Loss), before Tax of -$1.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-07-23
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$1.90M.
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$1.10M.
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$2.80M.
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$2.70M.
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$8.40M.
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$10.20M.
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$9.40M, a 329.27% decline from fiscal 2022.
- WEST PHARMACEUTICAL SERVICES, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $4.10M, a 192.86% increase from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.90M 10-Q · filed 2026-07-23 | -$3.00M 10-Q · filed 2026-07-23 | -$5.80M derived: sum of 3 quarters · filed 2026-07-23 | -$8.50M derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2026-03-31 | -$1.10M 10-Q · filed 2026-04-23 | -$3.90M derived: sum of 2 quarters · filed 2026-04-23 | -$6.60M derived: sum of 3 quarters · filed 2026-04-23 | -$8.30M derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-12-31 | -$2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$5.50M derived: sum of 2 quarters · filed 2026-02-17 | -$7.20M derived: sum of 3 quarters · filed 2026-07-23 | -$8.40M 10-K · filed 2026-02-17 | |||
| 2025-09-30 | -$2.70M 10-Q · filed 2025-10-23 | -$4.40M derived: sum of 2 quarters · filed 2026-07-23 | -$5.60M 10-Q · filed 2025-10-23 | -$8.50M derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-06-30 | -$1.70M 10-Q · filed 2026-07-23 | -$2.90M 10-Q · filed 2026-07-23 | -$5.80M derived: sum of 3 quarters · filed 2026-07-23 | -$9.90M derived: sum of 4 quarters · filed 2026-07-23 | |||
| 2025-03-31 | -$1.20M 10-Q · filed 2026-04-23 | -$4.10M derived: sum of 2 quarters · filed 2026-04-23 | -$8.20M derived: sum of 3 quarters · filed 2026-04-23 | -$10.20M derived: sum of 4 quarters · filed 2026-04-23 | |||
| 2024-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$7.00M derived: sum of 2 quarters · filed 2026-02-17 | -$9.00M derived: sum of 3 quarters · filed 2026-02-17 | -$10.20M 10-K · filed 2026-02-17 | |||
| 2024-09-30 | -$4.10M 10-Q · filed 2025-10-23 | -$6.10M derived: sum of 2 quarters · filed 2025-10-23 | -$7.30M 10-Q · filed 2025-10-23 | -$13.70M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-06-30 | -$2.00M 10-Q · filed 2025-07-24 | -$3.20M 10-Q · filed 2025-07-24 | -$9.60M derived: sum of 3 quarters · filed 2026-02-17 | -$11.40M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2024-03-31 | -$1.20M 10-Q · filed 2025-04-24 | -$7.60M derived: sum of 2 quarters · filed 2026-02-17 | -$9.40M derived: sum of 3 quarters · filed 2026-02-17 | -$9.70M derived: sum of 4 quarters · filed 2026-02-17 | |||
| 2023-12-31 | -$6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | -$8.20M derived: sum of 2 quarters · filed 2026-02-17 | -$8.50M derived: sum of 3 quarters · filed 2026-02-17 | -$9.40M 10-K · filed 2026-02-17 | |||
| 2023-09-30 | -$1.80M 10-Q · filed 2024-10-24 | -$2.10M derived: sum of 2 quarters · filed 2024-10-24 | -$3.00M 10-Q · filed 2024-10-24 | -$3.50M derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2023-06-30 | -$300.00K 10-Q · filed 2024-07-25 | -$1.20M 10-Q · filed 2024-07-25 | -$1.70M derived: sum of 3 quarters · filed 2025-02-18 | $500.00K derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2023-03-31 | -$900.00K 10-Q · filed 2024-04-25 | -$1.40M derived: sum of 2 quarters · filed 2025-02-18 | $800.00K derived: sum of 3 quarters · filed 2025-02-18 | $2.10M derived: sum of 4 quarters · filed 2025-02-18 | |||
| 2022-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $1.70M derived: sum of 2 quarters · filed 2025-02-18 | $3.00M derived: sum of 3 quarters · filed 2025-02-18 | $4.10M 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $2.20M 10-Q · filed 2023-10-26 | $3.50M derived: sum of 2 quarters · filed 2023-10-26 | $4.60M 10-Q · filed 2023-10-26 | $3.50M derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-06-30 | $1.30M 10-Q · filed 2023-07-27 | $2.40M 10-Q · filed 2023-07-27 | $1.30M derived: sum of 3 quarters · filed 2024-02-20 | $900.00K derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2022-03-31 | $1.10M 10-Q · filed 2023-04-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-20 | -$400.00K derived: sum of 3 quarters · filed 2024-02-20 | $2.20M derived: sum of 4 quarters · filed 2024-02-20 | |||
| 2021-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$1.50M derived: sum of 2 quarters · filed 2024-02-20 | $1.10M derived: sum of 3 quarters · filed 2024-02-20 | $1.40M 10-K · filed 2024-02-20 | |||
| 2021-09-30 | -$400.00K 10-Q · filed 2022-10-27 | $2.20M derived: sum of 2 quarters · filed 2022-10-27 | $2.50M 10-Q · filed 2022-10-27 | -$500.00K derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-06-30 | $2.60M 10-Q · filed 2022-07-28 | $2.90M 10-Q · filed 2022-07-28 | -$100.00K derived: sum of 3 quarters · filed 2023-02-21 | -$1.10M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2021-03-31 | $300.00K 10-Q · filed 2022-04-28 | -$2.70M derived: sum of 2 quarters · filed 2023-02-21 | -$3.70M derived: sum of 3 quarters · filed 2023-02-21 | -$1.70M derived: sum of 4 quarters · filed 2023-02-21 | |||
| 2020-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | -$4.00M derived: sum of 2 quarters · filed 2023-02-21 | -$2.00M derived: sum of 3 quarters · filed 2023-02-21 | $1.50M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | -$1.00M 10-Q · filed 2021-10-28 | $1.00M derived: sum of 2 quarters · filed 2021-10-28 | $4.50M 10-Q · filed 2021-10-28 | $5.60M derived: sum of 4 quarters · filed 2022-02-22 | |||
| 2020-06-30 | $2.00M 10-Q · filed 2021-07-30 | -$2.00M 10-Q · filed 2020-07-24 | $5.50M 10-Q · filed 2021-07-30 | -$5.50M 10-Q · filed 2020-07-24 | $6.60M derived: sum of 3 quarters · filed 2022-02-22 | $1.50M derived: sum of 4 quarters · filed 2022-02-22 | |
| 2020-03-31 | $3.50M 10-Q · filed 2021-04-30 | -$3.50M 10-Q · filed 2020-04-24 | $4.60M derived: sum of 2 quarters · filed 2022-02-22 | -$500.00K derived: sum of 3 quarters · filed 2022-02-22 | -$5.30M derived: sum of 4 quarters · filed 2022-02-22 | ||
| 2019-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$4.00M derived: sum of 2 quarters · filed 2022-02-22 | -$8.80M derived: sum of 3 quarters · filed 2022-02-22 | $4.60M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | -$5.10M 10-Q · filed 2020-10-23 | $5.10M 10-Q · filed 2019-10-29 | -$9.90M derived: sum of 2 quarters · filed 2020-10-23 | $3.50M 10-Q · filed 2020-10-23 | |||
| 2019-06-30 | -$4.80M 10-Q · filed 2020-07-24 | -$8.60M 10-Q · filed 2020-07-24 | |||||
| 2019-03-31 | -$3.80M 10-Q · filed 2020-04-24 | ||||||
| 2018-12-31 | $5.50M 10-K · filed 2021-02-23 | $0.00 10-K · filed 2019-02-28 | |||||
| 2018-09-30 | -$2.70M 10-Q · filed 2019-10-29 | -$3.90M derived: sum of 2 quarters · filed 2019-10-29 | -$3.50M derived: sum of 3 quarters · filed 2019-10-29 | ||||
| 2018-06-30 | -$1.20M 10-Q · filed 2019-07-29 | -$800.00K 10-Q · filed 2019-07-29 | |||||
| 2018-03-31 | $400.00K 10-Q · filed 2019-05-08 | ||||||
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 | ||||||
| 2016-12-31 | -$2.70M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |